Cara Therapeutics
CARA
$3.09
Share price
-2.83%
Change (1 day)
-62.95%
Change (1 year)
Categories
Market capitalization of Cara Therapeutics (CARA)
Market cap: $0.16 Billion
As of June 2023 Cara Therapeutics has a market cap of $0.16 Billion. This makes Cara Therapeutics the world's 6399th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cara Therapeutics from 2014 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $0.16 B | -71.1% |
| 2022 | $0.57 B | -11.37% |
| 2021 | $0.65 B | -13.64% |
| 2020 | $0.75 B | 0.17% |
| 2019 | $0.75 B | 46.4% |
| 2018 | $0.51 B | 28.81% |
| 2017 | $0.39 B | 57.47% |
| 2016 | $0.25 B | -44.84% |
| 2015 | $0.45 B | 102.13% |
| 2014 | $0.22 B |
End of Day market cap according to different sources
On Jun 1st, 2023 the market cap of Cara Therapeutics was reported to be:
$0.16 Billion
$0.16 Billion
$0.16 Billion
$0.16 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $401.60 B | 240,660.35% | 🇺🇸 USA |
 Pfizer PFE | $214.63 B | 128,571.64% | 🇺🇸 USA |
 Trevena TRVN | $11.62 M | -93.03% | 🇺🇸 USA |
 Recro Pharma
REPH | $0.12 B | -26.12% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 175.13% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $13.47 M | -91.92% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $11.9 M | -92.86% | 🇺🇸 USA |